Overview

Past:

Concept of backward integration from exporting to Manufacturing was conceived by Mr. Alok Kumar (Founder and Managing Director) in early millennium era when entire world was busy with Y2K issue. Lok-Beta commenced its activity in Apr-2002 from Mumbai, India with a range of Pharmaceuticals and Healthcare products across globe along with plan to establish its own ultra-modern manufacturing plant. First fully integrated Manufacturing Unit along with in house R&D center operationalized supported by warehouse as per GMP in 2008. First accreditations WHO-GMP, India received in sep-2009. First overseas head quarter established in the heart of Moscow city, Russia in 2006.

Present-:

Lok-Beta is currently investing heavily in the research and development of new Pharmaceuticals & Healthcare formulations. The next few years will see a stream of new.

Lok-Beta products being established in the market infrastructure:

• Total area of constructed(RCC) factory is 4500 sq.m
• Tables, Capsules Liquid Suspension, Syrup Ointment and Cream.
• GLP, FDA, GMP (Schedule M)  Maharashtra, India certified Laboratory, ISO 9001.2015
• WHO-GMP, PIC/s Compliance, EAEU GMP and other international accreditation
• Market: More than 21 countries in Asia, Africa and Latin America. At domestic front company has presence across Indian States.

Way Forward-:

• Skidel, Belarus plant- Oral dose Formulation & API manufacturing Unit. Manufacturing facility of OSD ready to commence to commercialize the products in 2nd quarter of 2026 ( API is under planning to renovate the facility upto 3^rd quarter of 2027)
• GOA plant focusing on Oncology manufacturing- OSD and Sterile formulation. Plant is commence its OSD commercialization and Sterile Injection facility will be commence on or before March 2026
• Annually 10 new products registration in various ROW market and regulated Market